Opko Acquires CLIA Lab
December 18, 2012
Opko Acquires CLIA Lab
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Opko Licenses Protein Biomarker Panel for Prostate Cancer to IHT
May 4, 2012 / GenomeWeb Daily News - Carmenta Acquires Option to License Stanford Technology for Preeclampsia Test
January 25, 2013 / GenomeWeb Daily News - Opko to Purchase OURLab CLIA Lab to Support US Launch of 4Kscore Prostate Cancer Dx
October 26, 2012 / ProteoMonitor - IHT Begins Selling Opko's Protein Biomarker Prostate Cancer Dx
October 5, 2012 / ProteoMonitor - Opko Health Revamping Peptoid-Based Diagnostic Platform, Prepping Alzheimer's Test for Market
July 27, 2012 / ProteoMonitor